Imaxio SA

Biopharma start-up fundraising more than doubled to $3.87bn in the second quarter versus the prior quarter, helped by initial public offerings, including the Actelion Pharmaceuticals Ltd. spinout

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar

Imaxio SA 181 – 203 Avenue Jean Jaurès69007 Lyon, France Phone: +33 4 37 65 55 00 Web Site: www.imaxio.com Contact: Alexandre LeVert, CEO Industry Segment: Biotechnology Business: Vaccine d

The vaccine industry has had its ups and downs the last two decades, as public opinion and investor perception have influenced both the use and production of these preventative medicines. It’s traditi